1997
DOI: 10.1002/(sici)1097-0290(19971120)56:4<441::aid-bit9>3.0.co;2-o
|View full text |Cite
|
Sign up to set email alerts
|

Production of recombinant human antithrombin III on 20-L bioreactor scale: Correlation of supernatant neuraminidase activity, desialylation, and decrease of biological activity of recombinant glycoprotein

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
10
0

Year Published

1998
1998
2016
2016

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 25 publications
(10 citation statements)
references
References 36 publications
0
10
0
Order By: Relevance
“…Our results indicate that the cellular machinery is not significantly affected by the progress of infection, in contrast to a previous report using Sf-21 cells (7). Moreover, the sialylated structures do not undergo significant extracellular degradation, in contrast to glycoproteins produced in CHO cells (18,19).…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Our results indicate that the cellular machinery is not significantly affected by the progress of infection, in contrast to a previous report using Sf-21 cells (7). Moreover, the sialylated structures do not undergo significant extracellular degradation, in contrast to glycoproteins produced in CHO cells (18,19).…”
Section: Discussionmentioning
confidence: 99%
“…Similarly, Licari et al report an activity of 0.14 mU/µg total protein (i.e., 8.4 nmol/h‚µg total protein) in Tn5B1-4 cells (8). It appears that our Tn-4s variant distinguishes itself from regular Tn5B1-4 cells and Tn4h cells, as well as from CHO cells (15,18,19), by the absence or by very low levels of sialidase. This absence can be a considerable advantage for the production of sialylated glycoproteins.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…This enzymatic activity increased over the batch process to reach 430 nmol/h/L in the supernatant at the end of the culture. Though quantitative information concerning sialidase activity remains very sparse, levels higher than 3000 nmol/h/L have been reported in CHO cell culture supernatants (33,56,57). Thus, the sialidase activity measured in our serum-containing medium seems to be relatively low, which is in good agreement with the slow but continuous desialylation of murine EPO observed by HPCE over the batch process.…”
Section: Profile Consistency Of the Desialylated N-linked Glycans Of mentioning
confidence: 99%
“…Nevertheless, AT is available from human plasma (Büntemeyer et al 1994; Munzert et al 1997), from the view of product safety and possible virus infection (retrovirus and hepatotropic viruses), AT production must be only way through recombinant DNA (rDNA) technology (Zettlmeissl et al 1987). AT has been produced using different expression systems like E. coli , Chinese hamster ovary cells and Pichia pastoris , COS 1 monkey kidney cells, BHK (baby hamster kidney) cells, Spodoptera frugiperda insect cells, and transgenic goat milk (Bock et al 1982; Wasley et al 1987; Zettlmeissl et al 1988, 1989; Gillespie et al 1991; Edmunds et al 1998), but yeast-based recombinant human antithrombin (rhAT) has been demonstrated only by Broker et al (1987).…”
Section: Introductionmentioning
confidence: 99%